Page last updated: 2024-08-21

maleimide and Lymphoma, B-Cell

maleimide has been researched along with Lymphoma, B-Cell in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abdollahi-Fard, A; Betting, DJ; Hurvitz, SA; Kafi, K; Timmerman, JM	1

Other Studies

1 other study(ies) available for maleimide and Lymphoma, B-Cell

Article	Year
Sulfhydryl-based tumor antigen-carrier protein conjugates stimulate superior antitumor immunity against B cell lymphomas. Journal of immunology (Baltimore, Md. : 1950), 2008, Sep-15, Volume: 181, Issue:6 Topics: Animals; Antigens, Neoplasm; Cancer Vaccines; Carrier Proteins; CD4-Positive T-Lymphocytes; Cell Line, Tumor; Cross-Linking Reagents; Glutaral; Humans; Immunization, Passive; Immunoglobulin Idiotypes; Lymphoma, B-Cell; Maleimides; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Neoplasm Transplantation; Vaccines, Conjugate	2008

Article

Year

Sulfhydryl-based tumor antigen-carrier protein conjugates stimulate superior antitumor immunity against B cell lymphomas.

Journal of immunology (Baltimore, Md. : 1950), 2008, Sep-15, Volume: 181, Issue:6

Topics: Animals; Antigens, Neoplasm; Cancer Vaccines; Carrier Proteins; CD4-Positive T-Lymphocytes; Cell Line, Tumor; Cross-Linking Reagents; Glutaral; Humans; Immunization, Passive; Immunoglobulin Idiotypes; Lymphoma, B-Cell; Maleimides; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Neoplasm Transplantation; Vaccines, Conjugate

2008